nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Ischaemia—Octreotide—thymus cancer	0.0512	0.0512	CcSEcCtD
Naratriptan—Haemorrhoids—Octreotide—thymus cancer	0.0318	0.0318	CcSEcCtD
Naratriptan—Hypothyroidism—Octreotide—thymus cancer	0.0291	0.0291	CcSEcCtD
Naratriptan—Neuralgia—Octreotide—thymus cancer	0.0269	0.0269	CcSEcCtD
Naratriptan—Burning sensation—Octreotide—thymus cancer	0.0269	0.0269	CcSEcCtD
Naratriptan—Neuritis—Octreotide—thymus cancer	0.025	0.025	CcSEcCtD
Naratriptan—Tingling sensation—Octreotide—thymus cancer	0.0232	0.0232	CcSEcCtD
Naratriptan—Stinging—Octreotide—thymus cancer	0.0231	0.0231	CcSEcCtD
Naratriptan—Numbness—Octreotide—thymus cancer	0.0225	0.0225	CcSEcCtD
Naratriptan—Sensory loss—Octreotide—thymus cancer	0.0216	0.0216	CcSEcCtD
Naratriptan—Muscle twitching—Octreotide—thymus cancer	0.019	0.019	CcSEcCtD
Naratriptan—Vaginal inflammation—Octreotide—thymus cancer	0.0187	0.0187	CcSEcCtD
Naratriptan—Cystitis noninfective—Octreotide—thymus cancer	0.0182	0.0182	CcSEcCtD
Naratriptan—Cystitis—Octreotide—thymus cancer	0.018	0.018	CcSEcCtD
Naratriptan—Vaginal infection—Octreotide—thymus cancer	0.0176	0.0176	CcSEcCtD
Naratriptan—Urine output increased—Octreotide—thymus cancer	0.0169	0.0169	CcSEcCtD
Naratriptan—Bladder pain—Octreotide—thymus cancer	0.0169	0.0169	CcSEcCtD
Naratriptan—Hyperkinesia—Octreotide—thymus cancer	0.0163	0.0163	CcSEcCtD
Naratriptan—Sleep disorder—Octreotide—thymus cancer	0.0157	0.0157	CcSEcCtD
Naratriptan—Polyuria—Octreotide—thymus cancer	0.0154	0.0154	CcSEcCtD
Naratriptan—Gastroenteritis—Octreotide—thymus cancer	0.0153	0.0153	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Naratriptan—Dehydration—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Naratriptan—Dry skin—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Naratriptan—Cramp muscle—Octreotide—thymus cancer	0.0122	0.0122	CcSEcCtD
Naratriptan—Gastritis—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Naratriptan—Asthma—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Naratriptan—Bronchitis—Octreotide—thymus cancer	0.0113	0.0113	CcSEcCtD
Naratriptan—Abdominal discomfort—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Naratriptan—Pollakiuria—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Naratriptan—Hyperglycaemia—Octreotide—thymus cancer	0.0106	0.0106	CcSEcCtD
Naratriptan—Pneumonia—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Naratriptan—Drowsiness—Octreotide—thymus cancer	0.0104	0.0104	CcSEcCtD
Naratriptan—Depression—Octreotide—thymus cancer	0.0104	0.0104	CcSEcCtD
Naratriptan—Neuropathy peripheral—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Naratriptan—Sinusitis—Octreotide—thymus cancer	0.0098	0.0098	CcSEcCtD
Naratriptan—Bradycardia—Octreotide—thymus cancer	0.00955	0.00955	CcSEcCtD
Naratriptan—Hypoaesthesia—Octreotide—thymus cancer	0.00933	0.00933	CcSEcCtD
Naratriptan—Tinnitus—Octreotide—thymus cancer	0.00875	0.00875	CcSEcCtD
Naratriptan—Cardiac disorder—Octreotide—thymus cancer	0.00871	0.00871	CcSEcCtD
Naratriptan—Immune system disorder—Octreotide—thymus cancer	0.00847	0.00847	CcSEcCtD
Naratriptan—Arrhythmia—Octreotide—thymus cancer	0.00838	0.00838	CcSEcCtD
Naratriptan—Alopecia—Octreotide—thymus cancer	0.00829	0.00829	CcSEcCtD
Naratriptan—Erythema—Octreotide—thymus cancer	0.00817	0.00817	CcSEcCtD
Naratriptan—Muscle spasms—Octreotide—thymus cancer	0.00785	0.00785	CcSEcCtD
Naratriptan—Vision blurred—Octreotide—thymus cancer	0.0077	0.0077	CcSEcCtD
Naratriptan—Tremor—Octreotide—thymus cancer	0.00765	0.00765	CcSEcCtD
Naratriptan—Ill-defined disorder—Octreotide—thymus cancer	0.00758	0.00758	CcSEcCtD
Naratriptan—Anaemia—Octreotide—thymus cancer	0.00755	0.00755	CcSEcCtD
Naratriptan—Agitation—Octreotide—thymus cancer	0.0075	0.0075	CcSEcCtD
Naratriptan—Malaise—Octreotide—thymus cancer	0.00736	0.00736	CcSEcCtD
Naratriptan—Vertigo—Octreotide—thymus cancer	0.00734	0.00734	CcSEcCtD
Naratriptan—Syncope—Octreotide—thymus cancer	0.00732	0.00732	CcSEcCtD
Naratriptan—Palpitations—Octreotide—thymus cancer	0.00722	0.00722	CcSEcCtD
Naratriptan—Loss of consciousness—Octreotide—thymus cancer	0.00718	0.00718	CcSEcCtD
Naratriptan—Cough—Octreotide—thymus cancer	0.00713	0.00713	CcSEcCtD
Naratriptan—Convulsion—Octreotide—thymus cancer	0.00708	0.00708	CcSEcCtD
Naratriptan—Arthralgia—Octreotide—thymus cancer	0.00695	0.00695	CcSEcCtD
Naratriptan—Myalgia—Octreotide—thymus cancer	0.00695	0.00695	CcSEcCtD
Naratriptan—Anxiety—Octreotide—thymus cancer	0.00693	0.00693	CcSEcCtD
Naratriptan—Discomfort—Octreotide—thymus cancer	0.00687	0.00687	CcSEcCtD
Naratriptan—Dry mouth—Octreotide—thymus cancer	0.0068	0.0068	CcSEcCtD
Naratriptan—Anaphylactic shock—Octreotide—thymus cancer	0.00666	0.00666	CcSEcCtD
Naratriptan—Oedema—Octreotide—thymus cancer	0.00666	0.00666	CcSEcCtD
Naratriptan—Infection—Octreotide—thymus cancer	0.00662	0.00662	CcSEcCtD
Naratriptan—Shock—Octreotide—thymus cancer	0.00656	0.00656	CcSEcCtD
Naratriptan—Nervous system disorder—Octreotide—thymus cancer	0.00654	0.00654	CcSEcCtD
Naratriptan—Thrombocytopenia—Octreotide—thymus cancer	0.00653	0.00653	CcSEcCtD
Naratriptan—Skin disorder—Octreotide—thymus cancer	0.00647	0.00647	CcSEcCtD
Naratriptan—Hyperhidrosis—Octreotide—thymus cancer	0.00644	0.00644	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00607	0.00607	CcSEcCtD
Naratriptan—Paraesthesia—Octreotide—thymus cancer	0.00598	0.00598	CcSEcCtD
Naratriptan—Dyspnoea—Octreotide—thymus cancer	0.00594	0.00594	CcSEcCtD
Naratriptan—Somnolence—Octreotide—thymus cancer	0.00592	0.00592	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Octreotide—thymus cancer	0.00575	0.00575	CcSEcCtD
Naratriptan—Fatigue—Octreotide—thymus cancer	0.00575	0.00575	CcSEcCtD
Naratriptan—Constipation—Octreotide—thymus cancer	0.0057	0.0057	CcSEcCtD
Naratriptan—Pain—Octreotide—thymus cancer	0.0057	0.0057	CcSEcCtD
Naratriptan—Feeling abnormal—Octreotide—thymus cancer	0.00549	0.00549	CcSEcCtD
Naratriptan—Urticaria—Octreotide—thymus cancer	0.00529	0.00529	CcSEcCtD
Naratriptan—Body temperature increased—Octreotide—thymus cancer	0.00527	0.00527	CcSEcCtD
Naratriptan—Hypersensitivity—Octreotide—thymus cancer	0.00491	0.00491	CcSEcCtD
Naratriptan—Asthenia—Octreotide—thymus cancer	0.00478	0.00478	CcSEcCtD
Naratriptan—Pruritus—Octreotide—thymus cancer	0.00472	0.00472	CcSEcCtD
Naratriptan—Diarrhoea—Octreotide—thymus cancer	0.00456	0.00456	CcSEcCtD
Naratriptan—Dizziness—Octreotide—thymus cancer	0.00441	0.00441	CcSEcCtD
Naratriptan—Vomiting—Octreotide—thymus cancer	0.00424	0.00424	CcSEcCtD
Naratriptan—Rash—Octreotide—thymus cancer	0.0042	0.0042	CcSEcCtD
Naratriptan—Dermatitis—Octreotide—thymus cancer	0.0042	0.0042	CcSEcCtD
Naratriptan—Headache—Octreotide—thymus cancer	0.00418	0.00418	CcSEcCtD
Naratriptan—Nausea—Octreotide—thymus cancer	0.00396	0.00396	CcSEcCtD
